chitosan has been researched along with Bile Duct Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, CW; Jeong, YI; Kang, DH; Kim, CH; Kim, DH; Kwak, TW; Lee, HM | 1 |
| Chung, CW; Chung, KD; Jeong, YI; Kang, DH; Kim, DH | 1 |
2 other study(ies) available for chitosan and Bile Duct Cancer
| Article | Year |
|---|---|
Ursodeoxycholic acid-conjugated chitosan for photodynamic treatment of HuCC-T1 human cholangiocarcinoma cells.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biological Transport; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Chlorophyllides; Cholangiocarcinoma; Drug Carriers; Humans; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Particle Size; Photochemotherapy; Photosensitizing Agents; Porphyrins; Reactive Oxygen Species; Technology, Pharmaceutical; Ursodeoxycholic Acid | 2013 |
Anti-tumor activity of all-trans retinoic acid-incorporated glycol chitosan nanoparticles against HuCC-T1 human cholangiocarcinoma cells.
Topics: Antineoplastic Agents; Apoptosis; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Chitosan; Cholangiocarcinoma; Dose-Response Relationship, Drug; Drug Carriers; Drug Compounding; Humans; Nanoparticles; Nanotechnology; Necrosis; Neoplasm Invasiveness; Particle Size; Technology, Pharmaceutical; Tretinoin | 2012 |